Ada Health is a global health company that simplifies healthcare journeys and helps people take care of themselves. Recently, the Berlin-based firm has secured $90 million (approx £63.3 million) funding in Series B round led by Leaps by Bayer, the impact investment arm of Bayer AG.
Other investors including Samsung Catalyst Fund, Vitruvian Partners, Inteligo Bank, F4, and Mutschler Ventures, also participated.
How will the funding be used?
The investment will be used to advance Ada’s popular health assessment technology and to grow its position in the United States. Besides funding, Bayer and Ada Health are in discussions about entering into a longer-term strategic partnership to support the company’s healthcare businesses.
The German health company was founded by doctors, scientists, and industry pioneers to create new possibilities for personal health.
AI-based health assessment
Co-founded by Claire Novorol, Daniel Nathrath, and Martin…